Dr. Shaukat Hayat, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 145 Hospital Ave, Suite 102, Du Bois, PA 15801 Phone: 814-375-3915 Fax: 814-375-3712 |
Dr. Manish Ranjan, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 Hospital Ave Ste 106, Du Bois, PA 15801 Phone: 814-503-4433 Fax: 814-503-4435 |
News Archive
The socioeconomic status of a country has long been considered a potentially significant factor in the availability of high-quality health-care interventions and even a determinant of long-term patient outcomes. A new study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation reports that in Europe, socioeconomic factors have a direct correlation to the rates and outcomes of stem cell transplantation for patients with acute myeloid leukemia (AML).
Omeros Corporation today announced that OMS721 has received orphan drug designation from the U.S. Food and Drug Administration for the treatment of Immunoglobulin A (IgA) nephropathy.
How do you measure the pain of a patient who can't communicate? A Rhode Island Hospital researcher studied an observational pain scale in cardiac surgery patients, and found that the Critical-Care Pain Observation Tool (CPOT) provided an accurate measure of a patient's pain level.
Hard to Treat Diseases (HTDS; http://www.htdsmedical.com/) and its operating subsidiary Slavica BioChem want to point the shareholders back to the press release from Oct 29, 2009, where the company announced news about a possible merger with a EU based, stem-cell research company.
Sensitive new quantitive methods could be used to detect small signs of increased tremor and impaired motor skills caused by exposure to certain metals, and to follow up the treatment of neurological disorders, reveals a thesis from the University of Gothenburg, Sweden.
› Verified 8 days ago